Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2012
10/26/2012CA2832865A1 Aminopyrimidine kinase inhibitors
10/26/2012CA2830138A1 Novel pesticidal pyrazole compounds
10/25/2012US20120270912 Substituted Indolealkanoic Acids
10/25/2012US20120270902 N-substituted benzene sulfonamides
10/25/2012US20120270892 Aminopyrimidine Kinase Inhibitors
10/25/2012US20120270877 IRE-1alpha INHIBITORS
10/25/2012US20120270875 Pyrimidine amide compounds
10/25/2012US20120270868 Rho kinase inhibitors
10/25/2012US20120270865 Heterocyclic compound
10/25/2012US20120270861 Primary Amines And Derivatives Thereof As Modulators Of The 5-HT2A Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto
10/25/2012US20120270859 Indoline derivatives and their use in treating disease-states such as cancer
10/25/2012US20120270858 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
10/25/2012US20120270856 Heteroaryloxy quinazoline derivatives
10/25/2012US20120270854 Antiviral Compounds
10/25/2012US20120270853 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
10/25/2012US20120269864 Arginine Derivatives with NP-I Antagonistic Activity
10/24/2012EP2514752A1 Epothilone compounds, preparation method and use thereof
10/24/2012EP2514750A1 Bromo-phenyl substituted thiazolyl dihydropyrimidines
10/24/2012EP2514749A1 Oxadiazole derivative having endothelial lipase inhibitory activity
10/24/2012EP2514748A1 2,4-diaminoquinazolines for spinal muscular atrophy
10/24/2012EP2514747A1 Substituted aminothiazine derivative
10/24/2012EP2513323A2 Heterologous hosts
10/24/2012EP2513118A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors
10/24/2012EP2513098A1 Aminopyrimidines as syk inhibitors
10/24/2012EP2513097A1 Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators
10/24/2012EP2513096A1 Substituted aminothiazolone indazoles as estrogen related receptor-a modulators
10/24/2012EP2513090A1 Compound suitable for the treatment of synucleopathies
10/24/2012EP2513071A1 Thiazole derivatives for treating diseases such as cancer
10/24/2012EP2513070A1 Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases
10/24/2012EP2513069A1 Antifungal compounds
10/24/2012EP2513068A1 Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of dpp-1
10/24/2012EP2513066A1 Sphingosine kinase inhibitors
10/24/2012EP2513054A1 Bicyclic derivatives useful as inhibitors of dpp-1
10/24/2012EP2513052A1 Pyrrolidine derivatives
10/24/2012EP2512466A1 Prodrugs of inhibitors of plasma kallikrein
10/24/2012EP2512246A1 Aminopyrimidines as syk inhibitors
10/24/2012EP2512243A1 Quinoline amide m1 receptor positive allosteric modulators
10/24/2012CN102753545A Oxadiazole derivative having endothelial lipase inhibitory activity
10/24/2012CN102753539A Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases
10/24/2012CN102753535A Quinazolines as potassium ion channel inhibitors
10/24/2012CN102753524A Bicyclic derivatives useful as inhibitors of dpp-1
10/24/2012CN102746297A Oxazolidinone antibiotics
10/24/2012CN102746296A Oxazolidinone antibiotics
10/24/2012CN102746290A Thiazole compound and preparation method thereof
10/24/2012CN102746289A Preparation method for lurasidone hydrochloride
10/24/2012CN102746281A 4-1,2,3-triazole-coumarin derivative and its preparation method and application
10/24/2012CN101567425B Organic electroluminescence device, novel platinum complex compound and novel compound capable of being a ligand thereof
10/23/2012US8293919 Antibacterial sulfone and sulfoxide substituted heterocyclic urea compounds
10/23/2012US8293774 Optically active (R)-aryloxypropionic acid amides and herbicidal composition comprising same
10/23/2012US8293769 CSF-1R inhibitors, compositions, and methods of use
10/23/2012US8293753 Substituted 2-carboxamide cycloamino ureas
10/23/2012US8293751 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/23/2012US8293747 Heterocyclic amide compounds as protein kinase inhibitors
10/23/2012CA2672903C Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer
10/23/2012CA2488635C Antagonists of melanin concentrating hormone receptor
10/18/2012WO2012142504A1 Aryl-or heteroaryl-substituted benzene compounds
10/18/2012WO2012141228A1 Novel pyrazole derivative
10/18/2012WO2012140642A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
10/18/2012WO2012140596A1 Glycoside derivatives and uses thereof
10/18/2012WO2012140419A1 Chromenone compounds as pi 3 -kinase inhibitors for the treatment of cancer
10/18/2012WO2012140061A1 Method for the preparation of substituted oxazolidinones
10/18/2012WO2012140001A1 Use of substituted dithiine-dicarboximides for combating phytopathogenic fungi
10/18/2012WO2012139499A1 Urea compounds as well as preparation methods, intermediates and uses thereof
10/18/2012WO2012139425A1 5-substituted iminothiazines and their mono-and dioxides as bace inhibitors,compositions,and their use
10/18/2012WO2009116085A3 An improved process for the preparation of ziprasidone
10/18/2012US20120264942 Method for screening osteopontin inhibitor and inhibitor obtained from the method
10/18/2012US20120264793 Pharmaceutical Use of 2',2-Bis-Thiazole Non-Nucleoside Compounds as Hepatitis C Virus Inhibitor
10/18/2012US20120264761 Aminobenzoquinazolinone M1 Receptor Positive Allosteric Modulators
10/18/2012US20120264760 Compounds and Methods for Treating Mammalian Gastrointestinal Parasitic Infections
10/18/2012US20120264735 Tyrosine kinase inhibitors
10/18/2012US20120264731 Chromenone derivatives
10/18/2012US20120264704 Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors
10/18/2012US20120264218 Induction of pluripotent cells
10/18/2012US20120263712 Pyrrolidine-1,2-dicarboxamide derivatives
10/18/2012US20120263679 Combinations Comprising Heterocyclic Inhibitors of MEK and Methods of Use Thereof
10/18/2012US20120263646 Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
10/18/2012US20120261650 Organic electroluminescent device
10/18/2012CA2832951A1 Glycoside derivatives and uses thereof
10/18/2012CA2832843A1 Aryl-or heteroaryl-substituted benzene compounds
10/18/2012CA2832822A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
10/18/2012CA2832787A1 Chromenone compounds as pi 3 - kinase inhibitors for the treatment of cancer
10/18/2012CA2832650A1 Novel pyrazole derivative
10/18/2012CA2832473A1 5-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions, and their use
10/17/2012EP2511269A1 Fused heterocyclic compound having amino group
10/17/2012EP2509978A1 Azocyclic inhibitors of fatty acid amide hydrolase
10/17/2012EP2509975A1 Benzimidazole inhibitors of leukotriene production
10/17/2012EP2509966A1 Amino oxazine derivatives
10/17/2012EP2509955A1 Pyrazole derivatives as modulators of calcium release -activated calcium channel
10/17/2012EP2509954A1 4 -oxo- 1h -quinoline- 3 - carboxamides as modulators of atp -binding cassette transporters
10/17/2012EP2509950A1 5-amino- 4-hydroxypentoyl amides
10/17/2012EP2509603A1 Methods of improving cognitive functions
10/17/2012CN1922171B Pyrimidine derivative
10/17/2012CN102731512A Preparation method of lurasidone intermediate and lurasidone
10/17/2012CN102731493A Anti-tumor compound containing benzothiazole heterocyclic structure and application thereof
10/17/2012CN102731490A Substituted isoxazoles as fungicides
10/17/2012CN102731413A Urea compound and its preparation method, intermediate and use
10/17/2012CN102731409A Pyridazinone compound, and pharmaceutical compositions, preparation method and use thereof
10/17/2012CN102731379A N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
10/17/2012CN101370772B Diketooxime ester compound and use thereof
10/17/2012CN101355879B Chemical compounds
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 628